The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Clinical features and outcomes of patients with breast cancer with leptomeningeal carcinomatosis.
 
Hemali Batra-Sharma
Stock and Other Ownership Interests - JJ Innovative Medicine (I)
Consulting or Advisory Role - MJH Life Sciences
 
Kay T Yeung
Stock and Other Ownership Interests - Esperion Therapeutics (I); Ionis Pharmaceuticals (I)
Consulting or Advisory Role - Kaneka Corporation (I)
Research Funding - BioFluidica (Inst); Dantari Pharmaceuticals (Inst); Immunomedics/Gilead (Inst); Ionis Pharmaceuticals (I); Jazz Pharmaceuticals (Inst); Kaneka Corporation (I); Seagen (Inst); Treadwell Therapeutics (Inst); Zymeworks (Inst)
 
Jessica Schulte
Consulting or Advisory Role - Alexion (Astra Zeneca); SpringWorks Therapeutics
Research Funding - Chimerix; VBI Vaccines
 
Jennifer Madeline Matro
Honoraria - OncLive/MJH Life Sciences; Pfizer
 
Heather Orosco
No Relationships to Disclose
 
Jona Hattangadi-Gluth
No Relationships to Disclose
 
David Eric Piccioni
No Relationships to Disclose
 
Rebecca Arielle Shatsky
Honoraria - Curio Science; IDEOlogy Health; OncLive/MJH Life Sciences; Vaniam Group
Consulting or Advisory Role - AstraZeneca; Stemline Therapeutics; The Dedham Group
Speakers' Bureau - Gilead Sciences
Research Funding - Genentech (Inst); OBI Pharma (Inst); Phoenix Molecular Designs (Inst); QuantumLeap Health (Inst)